One.Bio
Latest round
- Series A
Last raised
- Dec 2024
Total raised
- $43M
Investors
- 11
About One.Bio
,and Calyxo Biosystems offers a range of oligosaccharides with a variety of natural structures, as well as linkages between these structures and their roles as prebiotics and immunomodulatory. BCD Bioscience was formed as a spin-out from UC Davis. In April 2022, BCD Bioscience, Inc. As of 2022, Steve Watkins is the CEO of the company. The company provides a technology that produces prebiotics from a variety of natural fiber sources, as well as validated its science platform for prebiotic screening for functional properties such as the impact on live biotherapeutics, microbial composition and function, and active metabolites (postbiotics). The firm's platform provides information about carbohydrate structure and bacteria's use of prebiotics and also facilitates partnership and commercialization opportunities in both R&D and late-stage development.
Who invested in One.Bio
11 investors across 3 rounds
See all investors in One.Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about One.Bio
Who invested in One.Bio?
One.Bio has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has One.Bio raised?
One.Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did One.Bio last raise money?
One.Bio's most recent round on record is a Series A, in Dec 2024.
What does One.Bio do?
,and Calyxo Biosystems offers a range of oligosaccharides with a variety of natural structures, as well as linkages between these structures and their roles as prebiotics and immunomodulatory.
Where is One.Bio headquartered?
One.Bio is headquartered in Sacramento, US.
Which VCs invest in companies like One.Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at One.Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like One.Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.